Biopharmaceutical issues including suboptimal PK.
Poorly predictive models and assays in preclinical testing as well as the translation of results.
Immuneed, together with CTC Clinical Trial Consultants have joined forces to offer our clients a unique, integrated approach to overcome such obstacles and build value in early phase clinical trials.
To promote the benefits of this approach, “the preclinical human model”, we will visit the major cities in Sweden for a joint seminar. Earlier seminars in Lund and Gothenburg attracted many companies seeking to advance their current pipeline and now we look forward to visiting Stockholm as our next stop
08:45 Welcome and opening
09:00 From pre-clinical progress to clinical failure: is there a need for new models?
09:30 First-in-Human studies, where safety comes first
10:00 A unique model of fresh, circulating human blood with proven track record in advanced ex
10:30 Coffee break
10:45 Early Proof-of-Concept, build value in your clinical trial
11:15 Summary and closing
11:30 Lunch and discussion